Ascendis Pharma Correlations
ASND Stock | USD 165.54 2.48 1.48% |
The current 90-days correlation between Ascendis Pharma AS and Legend Biotech Corp is 0.1 (i.e., Average diversification). The correlation of Ascendis Pharma is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Ascendis Pharma Correlation With Market
Average diversification
The correlation between Ascendis Pharma AS and DJI is 0.1 (i.e., Average diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Ascendis Pharma AS and DJI in the same portfolio, assuming nothing else is changed.
Moving together with Ascendis Stock
0.75 | PFE | Pfizer Inc | PairCorr |
0.82 | CGEN | Compugen | PairCorr |
0.73 | KB | KB Financial Group | PairCorr |
0.72 | SHG | Shinhan Financial Earnings Call This Week | PairCorr |
0.71 | WF | Woori Financial Group Earnings Call Tomorrow | PairCorr |
0.65 | CSCO | Cisco Systems Sell-off Trend | PairCorr |
0.66 | IBM | International Business Earnings Call Tomorrow | PairCorr |
0.62 | MSFT | Microsoft | PairCorr |
0.65 | CVX | Chevron Corp | PairCorr |
Moving against Ascendis Stock
0.31 | BCH | Banco De Chile Earnings Call This Week | PairCorr |
0.47 | HPQ | HP Inc | PairCorr |
0.39 | PG | Procter Gamble Earnings Call This Week | PairCorr |
Related Correlations Analysis
Click cells to compare fundamentals | Check Volatility | Backtest Portfolio |
Correlation Matchups
Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.High positive correlations
| High negative correlations
|
Risk-Adjusted Indicators
There is a big difference between Ascendis Stock performing well and Ascendis Pharma Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Ascendis Pharma's multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.Mean Deviation | Jensen Alpha | Sortino Ratio | Treynor Ratio | Semi Deviation | Expected Shortfall | Potential Upside | Value @Risk | Maximum Drawdown | ||
---|---|---|---|---|---|---|---|---|---|---|
LEGN | 2.44 | 0.20 | 0.08 | 0.28 | 2.75 | 6.79 | 17.50 | |||
PCVX | 2.99 | 0.11 | 0.05 | 0.21 | 3.48 | 6.93 | 21.28 | |||
APLS | 2.48 | (0.05) | (0.02) | 0.08 | 2.69 | 5.62 | 18.33 | |||
TVTX | 2.87 | (0.03) | 0.01 | 0.11 | 4.86 | 5.57 | 28.16 | |||
AKRO | 2.50 | 0.45 | 0.13 | 0.95 | 2.54 | 5.49 | 30.05 | |||
ARGX | 1.58 | (0.16) | 0.00 | (0.16) | 0.00 | 3.07 | 11.12 | |||
ONC | 2.15 | 0.21 | 0.08 | 0.37 | 2.32 | 4.59 | 15.50 | |||
BPMC | 1.86 | 0.83 | 0.46 | (1.79) | 0.61 | 5.43 | 26.28 |
Ascendis Pharma Corporate Management
Michael LLM | Chief VP | Profile | |
Birgitte MD | Sr Affairs | Profile | |
Stina MD | Executive Oncology | Profile | |
Scott Holmes | Head Endocrinology | Profile | |
Timothy Lee | Director Relations | Profile | |
Jay Wu | Executive US | Profile | |
Nyssa Noyola | Vice Management | Profile |